Artelo Biosciences
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | 165 | |||
EBIT | -2,449 | |||
Net Income | -2,433 | -2,483 | -3,073 | -2,449 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -2,063 | -2,942 | -2,596 | -1,802 |
Cash | 881 | 1,195 | 2,815 | 2,639 |
Basic Shares | 3,227 | 3,227 | 3,188 | 2,949 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -10,285 | -7,443 | -4,714 | |
EBIT | -10,287 | -7,441 | -4,715 | |
Net Income | -9,289 | -9,874 | -7,437 | -4,654 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -8,207 | -8,008 | -6,141 | -4,347 |
Cash | 2,815 | 6,888 | 6,629 | 2,142 |
Basic Shares | 3,188 | 2,833 | 1,245 | 247 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.75 |
2024-05-31 | -$0.78 |
2024-03-31 | -$0.78 |
2024-02-29 | -$0.78 |
